Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 11/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LRRK2 | Q5S007 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7080256 | 0.86 | HSD17B10 (0.50) | SGMS2RXFP1MEN1KMT2A | |
| SCHEMBL7083339 | 0.84 | CAPN1 (0.46) | SGMS2RXFP1MEN1KMT2A | |
| SCHEMBL7077440 | 0.83 | MAPT (0.41) | SGMS2RXFP1MEN1KMT2A | |
| SCHEMBL7081568 | 0.83 | PTK2 (0.41) | SGMS2RXFP1 | |
| SCHEMBL7076729 | 0.75 | MTNR1B (0.45) | MEN1KMT2A | |
| SCHEMBL7083951 | 0.74 | SMN1; SMN2 (0.56) | RXFP1MEN1KMT2A | |
| SCHEMBL7083369 | 0.74 | RAB9A (0.43) | MEN1KMT2A | |
| SCHEMBL7080643 | 0.74 | RAB9A (0.43) | MEN1KMT2A | |
| SCHEMBL7078520 | 0.72 | ALDH1A1 (0.53) | MEN1KMT2A | |
| SCHEMBL7050569 | 0.71 | L3MBTL1 (0.62) | SGMS2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | AJINOMOTO CO. INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| US-6555584-B1 | Acetyl-coa carboxylase inhibitors | AJINOMOTO CO., INC. (JP) | 2003-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | ACSS2, ACACA, FASN | SGMS2 116/4885RXFP1 3117/4885MEN1 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.